11/19/2024
2:17 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
2:28 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
11:17 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:18 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/07/2024
3:31 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
7:52 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:14 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:13 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
2:45 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
5:02 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
11:15 PM | Nektar Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
4:30 PM | Nektar Therapeutics (Filer)
| Form 424B3 | |
05/28/2024
3:51 PM | Nektar Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/20/2024
8:12 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
8:13 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
8:14 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:36 PM | Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:12 PM | Nektar Therapeutics (Filer)
| Form ARS | |
04/17/2024
4:03 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
3:38 PM | Nektar Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/15/2024
3:18 PM | Nektar Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
03/14/2024
3:30 PM | Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2024
4:11 PM | Nektar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
7:40 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
7:16 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:17 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:19 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
2:50 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:51 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:16 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:50 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
3:25 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:07 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:18 AM | Nektar Therapeutics (Subject)
WHITFIELD ROY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Tesla Execs are Freaking Out (Ad) It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it.
And Elon Musk has completely restructured Tesla to chase this opportunity.
This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. |
11/27/2023
3:55 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
7:58 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:00 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:02 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
